LSE:0OIR

EURneffy approved as the first needle-free anaphylaxis treatment of adults and children in the UKEURneffy approved as the first needle-free anaphylaxis treatment of adults and children in the UK

EURneffy approved as the first needle-free anaphylaxis treatment of adults and children in the UK

Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has…

1 week ago
First market launch of the adrenaline nasal spray, EURneffy, for treatment of adults and children in GermanyFirst market launch of the adrenaline nasal spray, EURneffy, for treatment of adults and children in Germany

First market launch of the adrenaline nasal spray, EURneffy, for treatment of adults and children in Germany

ALK (ALKB:DC / OMX: ALK B) today announced the first market launch of EURneffy® 2 mg (the trade name for neffy® in…

1 month ago